Figure 2
Probability of rivaroxaban being cost effective at alternative willingness to pay thresholds: Acceptability Cost Effectiveness Curve.
Figure 2 | Cost Effectiveness and Resource Allocation
Probability of rivaroxaban being cost effective at alternative willingness to pay thresholds: Acceptability Cost Effectiveness Curve.